Medical Condition News

RSS

MD-CARE Act Amendments become law

Capping a two-year advocacy campaign led by Parent Project Muscular Dystrophy, today President Barack Obama signed the MD-CARE Act Amendments of 2014 into law, providing a significant victory to the Duchenne and broader muscular dystrophy communities.

27 Sep 2014

Virginia Tech participates in NCAA initiative to limit concussions among college athletes, military personnel

Virginia Tech is participating in a new, landmark $30 million national effort sponsored by the National Collegiate Athletic Association and the U.S. Department of Defense to combat concussions among college athletes and active service military personnel.

26 Sep 2014

Cedars-Sinai to participate in a consortium studying motor neuron disorders

Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of motor neuron disorders - such as Lou Gehrig's disease and spinal muscular atrophy - to a new, comprehensive perspective.

26 Sep 2014

New findings could pave way for treating autoimmune diseases

Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have established a clearer relationship between two cells which serve our body's natural defence mechanisms against diseases and infections.

26 Sep 2014

Virginia Tech participates in national effort to combat concussions

26 Sep 2014

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Bacillus anthracis bacteria have very efficient machinery for injecting toxic proteins into cells, leading to the potentially deadly infection known as anthrax. A team of MIT researchers has now hijacked that delivery system for a different purpose: administering cancer drugs.

26 Sep 2014

Imperial scientists map proteins affected by NMT enzyme, suggest potential way to treat cancer

Imperial chemists have gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped.

26 Sep 2014

Gastric bypass surgery provides better results than gastric banding

Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a new review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures.

26 Sep 2014

Researchers develop new strategy for reducing serious side effects of modern anticancer drugs

An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for reducing the often serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors).

26 Sep 2014

Scientists discover new clues about drug used in treating blood cancer

Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures.

26 Sep 2014

Survey: More than 70% of young cancer specialists across Europe show signs of burnout

Across Europe, more than 70% of young cancer specialists are showing signs of burnout, the largest survey of its kind has revealed. The results, reported at the Congress of the European Society for Medical Oncology (ESMO 2014) in Madrid, have prompted calls for serious action to address the issue at all levels.

26 Sep 2014

Dramatic videos of OSA patients increase CPAP usage

Like more than 20 million other Americans, John Brugger has been diagnosed with sleep apnea. He snored, tossed and turned and struggled to breathe during the night, which often left him not only exhausted the next day but also raised his risk of heart attack, stroke and car accidents.

26 Sep 2014

MicroBiome Therapeutics' NM 505 drug can improve tolerability of metformin

MicroBiome TherapeuticsTM LLC, today reported positive topline results from a proof of concept study testing whether its investigational drug, NM 505, can improve the tolerability of metformin, the first-line therapy for Type 2 diabetes worldwide.

26 Sep 2014

Access to potentially life-extending cancer drugs varies worldwide

Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show at the ESMO 2014 Congress in Madrid, Spain.

26 Sep 2014

Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope

Recent research, published yesterday, has identified a chemical transmitter in the brain that plays a vital role in Tourette Syndrome. This latest finding presents the potential for developing targeted, and therefore more effective, treatments to suppress the distressing symptoms of Tourette Syndrome.

26 Sep 2014

Anti-inflammatory treatment may prevent heterotopic ossification

An anti-inflammatory treatment, studied in the labs of regenerative medicine specialists and trauma surgeons, may prevent what's become one of the war-defining injuries for today's troops.

26 Sep 2014

Study finds that only half of U.S. adults screened for diabetes in last three years

A new cross-sectional study in American Journal of Preventive Medicine finds that only half of adults in the U.S. were screened for diabetes within the last three years, less than what is recommended by the American Diabetes Association.

26 Sep 2014

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.

26 Sep 2014

Study: Simple blood test could identify people with hypercalcaemia

High levels of calcium in blood, a condition known as hypercalcaemia, can be used by GPs as an early indication of certain types of cancer, according to a study by researchers from the universities of Bristol and Exeter.

26 Sep 2014

Thirteen research projects to explore nondrug approaches to manage pain, other health conditions

Thirteen research projects totaling approximately $21.7 million over 5 years will explore nondrug approaches to managing pain and related health conditions such as post-traumatic stress disorder (PTSD), drug abuse, and sleep issues. The effort seeks to enhance options for the management of pain and associated problems in U.S. military personnel, veterans, and their families.

26 Sep 2014

Medical Condition News

MD-CARE Act Amendments become law

Virginia Tech participates in NCAA initiative to limit concussions among college athletes, military personnel

Cedars-Sinai to participate in a consortium studying motor neuron disorders

New findings could pave way for treating autoimmune diseases

Virginia Tech participates in national effort to combat concussions

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Imperial scientists map proteins affected by NMT enzyme, suggest potential way to treat cancer

Gastric bypass surgery provides better results than gastric banding

Researchers develop new strategy for reducing serious side effects of modern anticancer drugs

Scientists discover new clues about drug used in treating blood cancer

Survey: More than 70% of young cancer specialists across Europe show signs of burnout

Dramatic videos of OSA patients increase CPAP usage

MicroBiome Therapeutics' NM 505 drug can improve tolerability of metformin

Access to potentially life-extending cancer drugs varies worldwide

Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope

Anti-inflammatory treatment may prevent heterotopic ossification

Study finds that only half of U.S. adults screened for diabetes in last three years

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Study: Simple blood test could identify people with hypercalcaemia

Thirteen research projects to explore nondrug approaches to manage pain, other health conditions

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News